Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
KLAR.ST
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
N/A
-0.22
vs -0.71
Q1.23
N/A
-0.06
vs -0.37
Q2.23
N/A
-0.09
vs -0.24
Q3.23
N/A
-0.10
vs -0.27
Q4.23
N/A
-0.09
vs -0.22
Q1.24
N/A
-0.11
vs -0.06
Q2.24
N/A
-0.11
vs -0.09
Q3.24
N/A
-0.06
vs -0.10
Q4.24
N/A
-0.11
vs -0.09
Q1.25
N/A
-0.01
vs -0.11
Sales Growth
YoY
Current
Estimates
Q4.22
-64%
2.2M vs 6.1M
Q1.23
NA
6.5M vs NA
Q2.23
-100%
NA vs 3.7M
Q3.23
NA
619K vs NA
Q4.23
-41%
1.3M vs 2.2M
Q1.24
-100%
10K vs 6.5M
Q2.24
NA
NA vs NA
Q3.24
-100%
NA vs 619K
Q4.24
-18%
1.1M vs 1.3M
Q1.25
+89750%
9M vs 10K
Return on Equity
QoQ
Q1.23
-8%
-0.08
vs -0.17
Q2.23
-17%
-0.17
vs -0.08
Q3.23
-21%
-0.21
vs -0.17
Q4.23
-23%
-0.23
vs -0.21
Q1.24
-41%
-0.41
vs -0.23
Q2.24
-60%
-0.60
vs -0.41
Q3.24
-61%
-0.61
vs -0.60
Q4.24
-471%
-4.71
vs -0.61
Institutionnal Ownership
Forecast
167%2026-Revenue
986%2026-EPS
-525%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Relative Strength
KLAR.ST
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression. It also focuses on the commercialization of cannabis/cannabinoids, including THC and CBD for medical and recreational applications. The company was founded in 2014 and is based in Uppsala, Sweden.
STO
Unprofitable
EPS improving
Unprofitable
EPS improving
0.13Â ( 26.53%)
Pre-market NaN$0.00 (0.00%)
Relative Strenght
Volume Buzz
96%
Earning Acce
No
Dist 52w H.
66%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How KLAR.ST compares to sector?